NexGen Press® range
Designed to align with GEA’s initiative to “drive product innovation with digitalization and a focus on the environment,” the NexGen Press® range represents the future of tablet compression for the pharmaceutical industry.
When designing the NexGen Press®, the best features of the previous ranges were kept, as they have proven to be invaluable in terms of enhancing productivity and flexibility.
For example, the unique Air Compensator technology — fitted to the pre- and main compression stations of every machine in the NexGen Press® range — allows to run the machine using either the industry-standard force control for weight and hardness, or to use one of the additional five compression modes. These compression modes, depending on how the air compensator is used during pre- and main compression, help to reduce capping, sticking and overcome other common production issues.
Modular by design, every NexGen Press® can be configured to fit specific applications — for now or the future — with predefined option packs:
Additional features such as punch face lubrication (iSpray), A2D tooling for increased capacity and PAT integration are also available.
Based on more than 20 years of industry expertise, the patented FAST CHANGEOVER Exchangeable Compression Module (FCO ECM) provides at-source containment and has at least a 50% smaller product-contact area compared with other models on the market.
Much more than a conventional exchangeable turret, the ECM is a sealed unit that’s isolated from the remainder of the tablet press and not only contains the turret and compression tooling, but all the press’s product-contact parts as well. At the end of a production run, the ECM can be removed from the machine in just 15 minutes. A duplicate, clean ECM can then be installed in the machine in another 15 minutes.
The ECM facilitates fast changeovers and enhanced operator and product safety, making the NexGen Press® range both efficient and versatile. It also benefits from multiple compression modes and a small footprint.
To respond to the increasing market demand for containment solutions, the standard FCO-ECM can be upgraded to allow you to produce OEB3 and/or significantly diluted highly potent products.
For high-containment applications, a stainless-steel version of the ECM (FCO HC-ECM) is available with a WOL or WIL pack, depending on customer requirements. This FCO HC-ECM is intended for OEB4–5 products such as oncology drugs and hormones.
Examples include high-volume generics, analgesics, anti-inflammatories, metformin, ibuprofen, paracetamol, effervescents, nutraceuticals and vitamins, antibiotics and penicillin, orodispersible tablets, MUPS and bilayer tablets, hormones and oncology products, orphan drugs and new chemical entities (small volume/high yield), microtablets, poorly flowing powders, heat- and moisture-sensitive products and those that require capping and/or antisticking solutions.
* NexGen Press® 30 and NexGen Press® 45 have been awarded the Add Better label for energy efficiency. For more details, check the specific product pages.
Featuring an innovative design that promotes operator (and environmental) safety and ease of use, the NexGen Press® range is modular, intuitive and cost-effective to run, combining unrivaled containment with fast product changeovers and the best price-performance tableting system..
Featuring an innovative design that promotes operator (and environmental) safety and ease of use, the NexGen Press® range is modular, intuitive and cost-effective to run, combining unrivaled containment with fast product changeovers and the best price-performance tableting system..
The commercial-scale PERFORMA D is the latest addition to GEA’s portfolio of rotary tablet presses. Designed for the reliable and cost-effective large-scale production of oral solid dosage forms, the new double-sided model combines the benefits of flexibility and robust performance for a wide range of formulations.
Based on the traditional concept of a live coal-mine canary, the 21st century equivalent from GEA is a continuous real-time monitoring system that’s been designed to detect breaches in contained pharmaceutical production lines. By providing an additional level of monitoring, the Digital Canary reduces the need for routine occupational health chec...
Инновационный процесс компании GEA является важной вехой в предварительной очистке такого биотоплива, как гидроочищенное растительное масло и экологически чистое авиационное топливо. Благодаря отказу от процесса отбеливания производители получают значительную экономию через снижение эксплуатационных расходов более чем на 50% и сокращение выбросов CO2 на 12%.
Изменение климата и растущее население планеты оказывают повышенное давление на энергоемкую пищевую промышленность, чтобы накормить больше людей и при этом не нанести вред планете. Джордж Шеперд, менеджер по глобальной технической устойчивости компании GEA, объясняет, как компания GEA использует свои инженерные ноу-хау, чтобы помочь переработчикам производить продукцию более устойчиво и при этом повысить производительность.